Xospata Tablet
Product Images NDC 0469-1425

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Xospata (NDC 0469-1425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Astellas Pharma Us, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xospata (gilteritinib) Tablets 40 mg Carton Label (Image 01)

Chemical structure of gilteritinib, the active ingredient in Xospata 40 mg oral tablets. The diagram shows the detailed molecular arrangement of the compound including rings and functional groups.*

FDA Label Image

Structural Formula Of Gilteritinib (Image 02)

A Kaplan-Meier survival curve comparing the probability of survival over time (in months) between two treatment groups: gilteritinib and chemotherapy. The graph includes censoring marks and a table below indicating the number of subjects at risk for each treatment group at various time points.*

FDA Label Image

Image 03

Packaging label for Xospata (gilteritinib) tablets 40 mg by Astellas Pharma US, Inc., showing a 90-tablet carton. The label includes storage instructions, dosage form, manufacturer details, and warnings such as 'Do not break, crush or chew tablets.' The label also has barcodes and a designated area for printing lot, expiration, and serialization information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.